IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Institutional Pharmacies in the US Industry Data and Analysis
Institutional pharmacies have consolidated and generated solid revenue growth over the past five years. The aging population and rising obesity rates are leading to higher incidences of age-related health conditions that are filling hospitals and depleting healthcare providers' pharmaceutical supplies faster. Increased federal support has offset the decline in private insurance coverage brought on by inflation and a shaky job market. Increased funding for Medicare and Medicaid has strengthened the financial health of institutional pharmacies' main clients as patients seek both essential and elective treatments. The dominance of major companies has enabled them to acquire competitors and increase their profit. Revenue is forecast to rise at a CAGR of 0.1% to an estimated $24.3 billion through 2025, including an expected 4.0% uptick in 2024 alone.
Access this data your way
The Institutional Pharmacies in the US Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
What's included in this industry analysis
IBISWorld's research coverage on the Institutional Pharmacies industry in the United States includes market sizing, forecasting, data and analysis from 2015-2030. The most recent publication was released December 2025.
About this industry
What's this industry report about?
The Institutional Pharmacies industry in the United States operates under the NAICS industry code OD5707. This industry comprises pharmacies that offer a range of services to residents of nursing homes, hospitals or hospice environments without an on-site pharmacy. In addition to supplying pharmaceuticals, institutional pharmacies also provide consulting services, which include monitoring the control, distribution and administration of drugs and assisting with regulatory compliance. Related terms covered in the Institutional Pharmacies industry in the United States include medicare part d, generic drug and brand name drug.
What's included in this industry?
Products and services covered in Institutional Pharmacies industry in the United States include Brand-name prescription medications, Generic prescription medications and Nonprescription medications.
What companies are included in this industry?
Companies covered in the Institutional Pharmacies industry in the United States include Omnicare Inc. and Pharmerica Corp.
Performance
What's included in the Performance chapter?
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Institutional Pharmacies industry in the United States.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
Products & Markets
What's included in the Products and Markets chapter?
The Products and Markets chapter covers detailed products and service segmentation and analysis of major markets for the for the Institutional Pharmacies industry in the United States.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
Geographic Breakdown
What's included in the Geographic Breakdown chapter?
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Institutional Pharmacies industry in the United States.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
Competitive Forces
What's included in the Competitive Forces chapter?
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Institutional Pharmacies industry in the United States. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
Companies
What's included in the Companies chapter?
The Companies chapter covers Key Takeaways, Market Share and Companies in the Institutional Pharmacies industry in the United States. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
External Environment
What's included in the External Environment chapter?
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Institutional Pharmacies industry in the United States. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
Financial Benchmarks
What's included in the Financial Benchmarks chapter?
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Institutional Pharmacies industry in the United States. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
Industry Data
What's included in the Industry Data chapter?
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Institutional Pharmacies industry in the United States.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is the market size of the Institutional Pharmacies industry in the United States in 2026?
The market size of the Institutional Pharmacies industry in the United States is $24.3bn in 2026.
How many businesses are there in the Institutional Pharmacies industry in the United States in 2025?
There are 1,101 businesses in the Institutional Pharmacies industry in the United States, which has declined at a CAGR of 2.8 % between 2020 and 2025.
How may import tariffs affect the Institutional Pharmacies industry in the United States?
The Institutional Pharmacies industry in the United States is unlikely to be materially impacted by import tariffs with imports accounting for a low share of industry revenue.
How may export tariffs affect the Institutional Pharmacies industry in the United States?
The Institutional Pharmacies industry in the United States is unlikely to be materially impacted by export tariffs with exports accounting for a low share of industry revenue.
Has the Institutional Pharmacies industry in the United States grown or declined over the past 5 years?
The market size of the Institutional Pharmacies industry in the United States has been growing at a CAGR of 0.1 % between 2020 and 2025.
What is the forecast growth of the Institutional Pharmacies industry in the United States over the next 5 years?
Over the next five years, the Institutional Pharmacies industry in the United States is expected to grow.
What are the biggest companies in the Institutional Pharmacies industry in the United States?
The biggest companies operating in the Institutional Pharmacies industry in the United States are Omnicare Inc. and Pharmerica Corp
What does the Institutional Pharmacies industry in the United States include?
Providing brand-name pharmaceuticals and Providing generic pharmaceuticals are part of the Institutional Pharmacies industry in the United States.
Which companies have the highest market share in the Institutional Pharmacies industry in the United States?
The company holding the most market share in the Institutional Pharmacies industry in the United States is Omnicare Inc..
How competitive is the Institutional Pharmacies industry in the United States?
The level of competition is high and increasing in the Institutional Pharmacies industry in the United States.
Cut through the noise with intelligence you can trust
